Supply of Reagents for Determining Levels of Mycophenolic Acid and Antifungal Drugs in Blood and Plasma

This tender is for the supply of reagents used to determine the levels of immunosuppressive drugs, mycophenolic acid, and antifungal drugs in blood and plasma samples. The primary objective is to procure high-quality reagents necessary for accurate and reliable laboratory testing. The determination of these drug levels is crucial for therapeutic drug monitoring, particularly in patients undergoing immunosuppressive therapy or treatment for fungal infections. The reagents are intended for use with high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS), a sophisticated analytical technique. The tender documents, specifically Annexes No. 2 and 8, provide detailed descriptions of the required reagents, their specifications, and the analytical methods to be employed. Bidders must demonstrate their ability to supply reagents that meet these stringent technical requirements and ensure consistent performance. This procurement is vital for supporting clinical diagnostics and patient management at the healthcare facility.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals and Laboratory. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.